This tool leverages longitudinal data from the Study of Women’s Health Across the Nation (SWAN) to deliver personalized 10-year cardiovascular risk estimates for midlife women.
This technology utilizes three-dimensional spheroid culture techniques to transform human pericytes isolated from the aortic adventitia into pluripotent cells.